|
What’s Inside: Tech Tour with ITJ; AcuraStem Receives $7M for ALS and FTD Therapy Development; Pasadena Case Study on Life Science Friendly Zoning Changes; and more.
|
We’re championing the progress made by California’s life science community and want to hear about your company’s latest scientific breakthrough, investment milestone, or commitment to creating positive change for our industry. Submit your story here for possible inclusion in an upcoming issue. |
|
|
What’s Happening at Biocom California
|
|
Biocom California Renews Partnership with Nucleate to Empower Biotech Leaders
We are excited to announce the renewal of our strategic partnership with Nucleate for the third consecutive year, which educates and empowers scientists and business students with tools to start new ventures. This partnership has yielded substantial results, including hosting impactful workshops and engaging Biocom California members with Nucleate’s Final Pitch showcase. As we continue to foster a diverse talent pipeline to drive the growth of California’s life science ecosystem, we are proud to collaborate with Nucleate in its mission to enhance the global innovation landscape by accelerating impactful academic bioventures.
|
|
Join the Binational Life Science Tech Tour in Baja with ITJ
Biocom California’s VP of Strategic Operations and San Diego Head, Miguel Motta, will be representing life sciences in the Binational Life Science Tech Tour on February 21, hosted by ITJ. Life science executives from San Diego, Orange County, and Tijuana will discuss biotech and medtech binational ecosystem opportunities, aiming to learn about nearshoring success stories, supply chain, talent development, and trending topics such as new product design, AI, cyber, and software development in the San Diego-Tijuana Mega Region. To learn more or participate, reach out to Patricia Hernandez.
|
|
|
|
Converge Meet-Ups to Kick-Off in the Bay Area
Following the launch of Converge by Biocom California, a cross-sector community bringing together the brightest minds in technology and life science, we are kicking off a series of conversations with our first Converge Meet-Up taking place at The Hub at Stanford Research Park on February 8. This gathering will feature lightning talks that will delve into how AI & ML are aiding in drug discovery, protein EnGPT, LLM in AI x Bio, and biosecurity, with speakers from BioMap Ventures, Future House, Rhea’s Factory, Spinx Bio, and Uniphage.
|
|
San Diego Festival of Science & Engineering 2024
The 2024 San Diego Festival of Science & Engineering returns on March 2 at Snapdragon Stadium for an immersive and inspiring event. This annual event, which is the largest of its kind in California, is a collective effort between industry, business leaders, government, community organizations, public outreach centers, academia, schools and school districts, and parents. Hands-on, interactive activities paired with science, technology, engineering, arts, and math entertainment excite minds of all ages and inspire the next generation of innovators. Learn more about attending or volunteering by visiting the Festival website. For corporate involvement, contact Silvana DelPiccolo.
|
|
|
|
|
|
|
Industry Intelligence & Member Moments
|
- AcuraStem received $7 million in funding from the NIH and DOD to accelerate therapies for ALS and FTD.
- Argonaut Manufacturing Services and KBI Biopharma forged a strategic alliance to support global biopharmaceutical companies with integrated drug substance and drug product solutions.
- Bench International and Ashton Tweed formed a strategic alliance to bring additional resources and service offerings to each company’s client base, including fractional executive hires.
- Cytiva and Pall Life Sciences completed their integration and are now one business under the Cytiva brand, offering an expanded and differentiated portfolio.
- EicOsis initiated a phase 1b trial of sEH inhibitor EC5026 to treat pain and inflammation in multiple conditions.
- Gilead committed to investing $320 million in Arcus Biosciences to own 33 percent of the company and accelerate the development of an experimental immunotherapy.
- Kite Pharma received FDA approval for its new manufacturing process change for Yescarta, shortening the manufacturing time from an average of seven days to five days.
- Kura Oncology released new data from its phase 1b trial showing oral leukemia treatment performed best on top of a standard-of-care combo regimen in newly diagnosed patients with specific mutations.
- Mobile Xpress Clinic has available lab and office space suited for start-up life science companies at its MXC Innovation Center in Sorrento Mesa.
- Sapien Biosciences published the mutational landscape of 53 Indian non-small cell lung cancers which showed that a substantial 79 percent of the cases exhibited clinically actionable gene variants.
- SciNote Electronic Lab Notebook and Ganymede Bio partnered to streamline instrument integration and scientific data reporting within laboratories.
- USC Keck School of Medicine stem cell scientists have developed a game-changing organoid model to study human cerebellar development and disease.
|
|
|
|
Transit Roundtable with San Diego Councilmembers
The Metropolitan Transit System Board of Directors voted last year to discontinue shuttle service from the Sorrento Valley COASTER station. Join us on February 14 for a Roundtable with the North County Transit District and Councilmembers Joe LaCava and Kent Lee to discuss the future of transit in San Diego’s life science hub and any city issues you wish to address.
|
|
Biocom California Releases Pasadena Case Study
Following the passage of a package of zoning changes that our policy team worked closely with the City of Pasadena on, we are pleased to release the Pasadena Case Study as an example of how decision makers can help make their cities more life science friendly.
|
|
City of Palo Alto’s New Mayor and Vice Mayor
Palo Alto’s City Council elected former Vice Mayor Greer Stone as Mayor and Council Member Ed Lauing as Vice Mayor for the coming calendar year. Biocom California looks forward to continuing to work with the city in advocating on behalf of our life science members in the region.
|
|
Biocom California
For over 28 years, Biocom California has helped move the life science industry forward with transformative resources that enable companies to make meaningful connections. With a membership base of over {{{dynamic_content_1600}}} companies, we connect our members to each other so they can collaborate and work stronger and smarter together. We connect organizations to capital investment and purchasing solutions so they can grow faster and work more efficiently. We’re their link to advocacy that fights for innovation and we provide an environment where their business and talent can thrive. Biocom California is how the life science industry gets connected.
|
|
|
